119 related articles for article (PubMed ID: 7591233)
1. Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma.
Nakagomi H; Pisa P; Pisa EK; Yamamoto Y; Halapi E; Backlin K; Juhlin C; Kiessling R
Int J Cancer; 1995 Nov; 63(3):366-71. PubMed ID: 7591233
[TBL] [Abstract][Full Text] [Related]
2. Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytes.
Wang Q; Redovan C; Tubbs R; Olencki T; Klein E; Kudoh S; Finke J; Bukowski RM
Int J Cancer; 1995 Jun; 61(6):780-5. PubMed ID: 7790111
[TBL] [Abstract][Full Text] [Related]
3. Host immune response in renal cell cancer: interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected tumor-infiltrating lymphocytes.
Maeurer MJ; Martin DM; Castelli C; Elder E; Leder G; Storkus WJ; Lotze MT
Cancer Immunol Immunother; 1995 Aug; 41(2):111-21. PubMed ID: 7656270
[TBL] [Abstract][Full Text] [Related]
4. T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors.
Alexander JP; Kudoh S; Melsop KA; Hamilton TA; Edinger MG; Tubbs RR; Sica D; Tuason L; Klein E; Bukowski RM
Cancer Res; 1993 Mar; 53(6):1380-7. PubMed ID: 8443817
[TBL] [Abstract][Full Text] [Related]
5. Enhanced expression of IFN-gamma mRNA in CD4(+)or CD8(+)tumour-infiltrating lymphocytes compared to peripheral lymphocytes in patients with renal cell cancer.
Elsässer-Beile U; Rindsfüser M; Grussenmeyer T; Schultze-Seemann W; Wetterauer U
Br J Cancer; 2000 Sep; 83(5):637-41. PubMed ID: 10944605
[TBL] [Abstract][Full Text] [Related]
6. Expression of cytokine mRNA transcripts in renal cell carcinoma.
Olive C; Cheung C; Nicol D; Falk MC
Immunol Cell Biol; 1998 Aug; 76(4):357-62. PubMed ID: 9723777
[TBL] [Abstract][Full Text] [Related]
7. Chemokine gene expression in the murine renal cell carcinoma, RENCA, following treatment in vivo with interferon-alpha and interleukin-2.
Sonouchi K; Hamilton TA; Tannenbaum CS; Tubbs RR; Bukowski R; Finke JH
Am J Pathol; 1994 Apr; 144(4):747-55. PubMed ID: 8160774
[TBL] [Abstract][Full Text] [Related]
8. The cytokine microenvironment of human colon carcinoma. Lymphocyte expression of tumor necrosis factor-alpha and interleukin-4 predicts improved survival.
Barth RJ; Camp BJ; Martuscello TA; Dain BJ; Memoli VA
Cancer; 1996 Sep; 78(6):1168-78. PubMed ID: 8826937
[TBL] [Abstract][Full Text] [Related]
9. In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon-alpha gene transfer.
Hathorn RW; Tso CL; Kaboo R; Pang S; Figlin R; Sawyers C; deKernion JB; Belldegrun A
Cancer; 1994 Oct; 74(7):1904-11. PubMed ID: 7521786
[TBL] [Abstract][Full Text] [Related]
10. The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumor-infiltrating lymphocytes.
Lüscher U; Filgueira L; Juretic A; Zuber M; Lüscher NJ; Heberer M; Spagnoli GC
Int J Cancer; 1994 May; 57(4):612-9. PubMed ID: 8181865
[TBL] [Abstract][Full Text] [Related]
11. Semiquantitative analysis of Th1 and Th2 cytokine expression in CD3+, CD4+, and CD8+ renal-cell-carcinoma-infiltrating lymphocytes.
Elsässer-Beile U; Grussenmeyer T; Gierschner D; Schmoll B; Schultze-Seemann W; Wetterauer U; Schulte Mönting J
Cancer Immunol Immunother; 1999 Jul; 48(4):204-8. PubMed ID: 10431690
[TBL] [Abstract][Full Text] [Related]
12. Lymphokine mRNA expression by transplantable murine B lymphocytic malignancies. Tumor-derived IL-10 as a possible mechanism for modulating the anti-tumor response.
Bost KL; Bieligk SC; Jaffe BM
J Immunol; 1995 Jan; 154(2):718-29. PubMed ID: 7814878
[TBL] [Abstract][Full Text] [Related]
13. Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape.
Rayman P; Uzzo RG; Kolenko V; Bloom T; Cathcart MK; Molto L; Novick AC; Bukowski RM; Hamilton T; Finke JH
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S81-7. PubMed ID: 10685665
[TBL] [Abstract][Full Text] [Related]
14. Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies.
Pisa P; Halapi E; Pisa EK; Gerdin E; Hising C; Bucht A; Gerdin B; Kiessling R
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7708-12. PubMed ID: 1502188
[TBL] [Abstract][Full Text] [Related]
15. Expression of mRNA for cytokines in tumor-infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer.
Vitolo D; Zerbe T; Kanbour A; Dahl C; Herberman RB; Whiteside TL
Int J Cancer; 1992 Jun; 51(4):573-80. PubMed ID: 1601521
[TBL] [Abstract][Full Text] [Related]
16. High incidence of interleukin 10 mRNA but not interleukin 2 mRNA detected in human breast tumours.
Venetsanakos E; Beckman I; Bradley J; Skinner JM
Br J Cancer; 1997; 75(12):1826-30. PubMed ID: 9192989
[TBL] [Abstract][Full Text] [Related]
17. Intraepithelial lymphocytes in human gut have lytic potential and a cytokine profile that suggest T helper 1 and cytotoxic functions.
Lundqvist C; Melgar S; Yeung MM; Hammarström S; Hammarström ML
J Immunol; 1996 Sep; 157(5):1926-34. PubMed ID: 8757311
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 and TNF alpha production in human renal cell carcinoma.
Gogusev J; Augusti M; Chrétien Y; Droz D
Kidney Int; 1993 Sep; 44(3):585-92. PubMed ID: 8231032
[TBL] [Abstract][Full Text] [Related]
19. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
20. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
